December 18, 2018

Tuesday, December 18

5:00 – 6:00

Registration & Networking

6:00 – 6:05

Welcome and Opening Remarks

Bob Buderi, Xconomy

6:05 – 6:15

From Hope to Reality: The Expansion of Life Sciences in NYC

Maria Gotsch, Partnership Fund for NYC

6:15 – 6:45

The Rgenix Story

Three brothers spun Rgenix out of Rockefeller University based on a technology meant to uncover cancer targets that others haven’t been able to find. It just raised a $40 million Series C and has a drug in human testing

Masoud Tavozoie, Rgenix
David Darst, Rgenix

6:45 – 7:15

The Quentis Therapeutics Story

Formed from the labs of former Weill Cornell Medicine dean Laurie Glimcher, Quentis is developing cancer drugs that counteract a method cells use to respond to stress. The startup is a product of Highline Therapeutics, a New York biotech incubator run by Versant Ventures

Carlo Rizzuto, Quentis Therapeutics; Versant Ventures
Michael Aberman, Quentis Therapeutic

7:15 – 7:45

The Flatiron Health Story

Started by two young New York entrepreneurs, Nat Turner and Zach Weinberg, this developer of cancer-specific software was sold to Roche for $1.9 billion earlier this year.

Bobby Green, Flatiron Health
Marta Bralic Kerns, Flatiron Health

7:45 – 8:45

Networking Reception

Please note that this schedule is subject to change.

Register Now